Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.36)
# 4,294
Out of 5,124 analysts
20
Total ratings
28.57%
Success rate
-27.92%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $64 → $66 | $49.00 | +34.69% | 2 | Nov 12, 2025 | |
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $45.74 | +26.80% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $4.49 | +479.71% | 2 | Mar 13, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.74 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $3.74 | - | 1 | Oct 5, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $1.48 | +24,427.03% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $3.66 | +2,359.02% | 1 | Aug 4, 2022 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.26 | +455.56% | 1 | Jun 21, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $52 | $2.80 | +1,757.14% | 1 | Apr 19, 2021 | |
| TENX Tenax Therapeutics | Upgrades: Buy | n/a | $12.20 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.60 | - | 5 | Apr 27, 2017 |
Harrow
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $66
Current: $49.00
Upside: +34.69%
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $45.74
Upside: +26.80%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $4.49
Upside: +479.71%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.74
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.74
Upside: -
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $1.48
Upside: +24,427.03%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $3.66
Upside: +2,359.02%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.26
Upside: +455.56%
Nano-X Imaging
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $2.80
Upside: +1,757.14%
Tenax Therapeutics
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $12.20
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $40.60
Upside: -